KAPA — KAIROS PHARMA LTD
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
基本面(SEC EDGAR XBRL)
财务数据来自 SEC company facts,每项均按 EDGAR 提交日期做 point-in-time 对齐。
| 营收 TTM | 营收同比 | 净利 TTM | 净利同比 | ROE(TTM) | 毛利率 | 净利率 | 市盈率(TTM) | PE 分位 | 市净率 | PB 分位 |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
华尔街分析师共识
评级、12 个月目标价与 EPS 预期,来自 Nasdaq 公开分析师数据接口。 · 抓取于 2026-11-19
| 财季截止 | 共识 EPS 预期 | 前瞻市盈率 | 最高 EPS | 最低 EPS | 预测机构数 | 近 4 周修正(上调/下调) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.77 | — | -0.77 | -0.77 | 1 | — |
| 财年截止 | 共识 EPS 预期 | 前瞻市盈率 | 最高 EPS | 最低 EPS | 预测机构数 | 近 4 周修正(上调/下调) |
|---|---|---|---|---|---|---|
| Dec 2026 | -2.59 | — | -2.59 | -2.59 | 1 | — |
| Dec 2027 | -4.69 | — | -4.69 | -4.69 | 1 | — |
| Dec 2028 | -5.11 | — | -5.11 | -5.11 | 1 | — |
前瞻市盈率 = 抓取时现价 ÷ 共识 EPS(季度数据 ×4 年化)。修正分 =(上调 − 下调)÷ 预测机构数,来自 Nasdaq 近 4 周统计。 来源: Nasdaq analyst data
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
截至Q3 2026,共 6 家机构在其最新 13F 申报中持有 KAPA(KAIROS PHARMA LTD),合计申报市值 $57.80K,对应 35.21K 股。按股数计算较上季度减持 90.4%(-306.81K 股),申报市值环比下降 58.9%。持仓集中度较高:前五大持有人占申报市值的 97.1%,前十大的集中度为 100.0%。
与上一季度相比,1 家新建仓位、5 家减仓、9 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q3 2026 末的持仓状态,并非实时交易。
KAIROS PHARMA LTD(KAPA)的主要机构持有人包括 ARMISTICE CAPITAL, LLC、UMB Bank, n.a.、Citadel Advisors,按 13F 申报市值在本页 30 家持有人中排名居前。
KAPA 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 6 | 35.21K | $57.80K | -90.4% |
| Q2 2026 | 14 | 1.02M | $392.13K | -6.5% |
| Q1 2026 | 11 | 601.06K | $341.51K | -5.3% |
| Q4 2025 | 14 | 855.72K | $607.47K | +23.9% |
| Q3 2025 | 14 | 445.02K | $505.84K | +2.0% |
| Q2 2025 | 10 | 218.72K | $172.89K | +7.2% |
| Q1 2025 | 8 | 1.58M | $1.46M | -26.5% |
| Q4 2024 | 5 | 406.60K | $618.27K | -58.3% |
表内 8 个季度中,机构持股合计减少 91%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2024(-58.3%)。
前 25 大机构持仓人(Q3 2026) — 6 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 13.60K | $22.30K | 0.00% | 减持 | |
| 9.71K | $15.92K | 0.00% | 减持 | |
| 6.87K | $11.27K | 0.00% | 减持 | |
| 2.52K | $4.18K | 0.00% | 新进 | |
| 1.49K | $2.44K | 0.00% | 减持 | |
| 1.03K | $1.69K | 0.00% | 减持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 14 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 309.83K | $118.88K | 0.00% | 新进 | |
| 231.88K | $89.04K | 0.00% | 持有 | |
| 82.09K | $31.00K | 0.00% | 新进 | |
| 78.92K | $30.28K | 0.00% | 新进 | |
| 78.92K | $30.28K | 0.00% | 减持 | |
| 63.88K | $24.53K | 0.00% | 持有 | |
| 44.29K | $17.09K | 0.00% | 持有 | |
| 44.29K | $16.99K | 0.00% | 持有 | |
| 33.75K | $12.95K | 0.00% | 新进 | |
| 29.29K | $11.24K | 0.00% | 新进 | |
| 14.92K | $5.72K | 0.00% | 新进 | |
| 6.26K | $2.40K | 0.00% | 新进 | |
| 3.73K | $1.43K | 0.00% | 减持 | |
| 723 | $277 | 0.00% | 新进 |
Q1 2026 — 11 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 231.88K | $129.62K | 0.00% | 新进 | |
| 111.29K | $62.21K | 0.00% | 增持 | |
| 63.88K | $35.71K | 0.00% | 新进 | |
| 44.29K | $30.33K | 0.01% | 持有 | |
| 44.29K | $24.76K | 0.00% | 持有 | |
| 39.54K | $22.11K | 0.00% | 减持 | |
| 24.10K | $13.47K | 0.00% | 持有 | |
| 21.57K | $12.00K | 0.00% | 增持 | |
| 16.25K | $9.08K | 0.00% | 新进 | |
| 3.96K | $2.21K | 0.00% | 减持 | |
| 10 | $6 | 0.00% | 新进 |
Q4 2025 — 14 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 321.74K | $228.43K | 0.00% | 新进 | |
| 131.83K | $93.60K | 0.00% | 持有 | |
| 94.01K | $66.75K | 0.00% | 增持 | |
| 72.83K | $51.71K | 0.00% | 增持 | |
| 48.49K | $34.43K | 0.00% | 增持 | |
| 44.29K | $31.89K | 0.01% | 持有 | |
| 44.29K | $31.44K | 0.00% | 持有 | |
| 24.10K | $17.11K | 0.00% | 持有 | |
| 21.32K | $15.00K | 0.00% | 新进 | |
| 20.28K | $14.00K | 0.00% | 新进 | |
| 15.14K | $10.75K | 0.00% | 新进 | |
| 13.04K | $9.26K | 0.00% | 新进 | |
| 4.23K | $3.00K | 0.00% | 减持 | |
| 134 | $95 | 0.00% | 减持 |
Q3 2025 — 14 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 131.83K | $154.24K | 0.00% | 新进 | |
| 65.80K | $76.98K | 0.00% | 增持 | |
| 45.79K | $53.57K | 0.00% | 新进 | |
| 44.29K | $51.81K | 0.00% | 持有 | |
| 44.29K | $37.65K | 0.01% | 持有 | |
| 24.89K | $29.13K | 0.00% | 增持 | |
| 24.10K | $28.20K | 0.00% | 新进 | |
| 23.50K | $27.00K | 0.01% | 新进 | |
| 14.89K | $17.42K | 0.00% | 新进 | |
| 12.41K | $14.52K | 0.00% | 减持 | |
| 5.98K | $7.00K | 0.00% | 减持 | |
| 5.96K | $6.97K | 0.00% | 增持 | |
| 1.00K | $1.00K | 0.00% | 新进 | |
| 304 | $356 | 0.00% | 增持 |
Q2 2025 — 10 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 44.29K | $49.60K | 0.01% | 持有 | |
| 62.75K | $44.49K | 0.00% | 新进 | |
| 44.29K | $31.40K | 0.00% | 持有 | |
| 21.80K | $15.46K | 0.00% | 增持 | |
| 13.55K | $9.61K | 0.00% | 新进 | |
| 13.24K | $9.00K | 0.00% | 新进 | |
| 9.46K | $6.71K | 0.00% | 增持 | |
| 5.50K | $3.90K | 0.00% | 新进 | |
| 3.80K | $2.69K | 0.00% | 新进 | |
| 51 | $36 | 0.00% | 增持 |
新建仓(Q3 2026)
- Nuveen, LLC 2.52K 股 · $4.18K
完全清仓(较上季)
- Citadel Advisors 卖出 309.83K 股 · $118.88K
- Virtu Financial LLC 卖出 82.09K 股 · $31.00K
- GEODE CAPITAL MANAGEMENT, LLC 卖出 78.92K 股 · $30.28K
- Geode Capital Management 卖出 78.92K 股 · $30.28K
- SevenBridge Financial Group, LLC 卖出 44.29K 股 · $17.09K
- Aptus Capital Advisors, LLC 卖出 44.29K 股 · $16.99K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 卖出 29.29K 股 · $11.24K
- XTX Topco Ltd 卖出 14.92K 股 · $5.72K
- BARCLAYS PLC 卖出 723 股 · $277
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 13.60K | 33.75K | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.71K | 231.88K | 231.88K | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 6.87K | 63.88K | 63.88K | — | — | — | — | — | — |
| Nuveen, LLC | 2.52K | — | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 1.49K | 3.73K | 3.96K | 4.23K | 5.96K | 3.80K | — | — | — |
| UBS Group AG | 1.03K | 6.26K | — | — | 5.98K | 9.46K | 2.79K | 10.85K | — |
| ARMISTICE CAPITAL, LLC | — | — | — | — | — | — | 1.40M | — | — |
| UMB Bank, n.a. | — | — | — | — | — | — | — | 371.12K | — |
| Citadel Advisors | — | 309.83K | — | 321.74K | — | — | 13.23K | 10.97K | — |
| Vanguard Group | — | — | — | 131.83K | 131.83K | — | — | — | — |
| Geode Capital Management | — | 78.92K | 111.29K | 72.83K | 65.80K | 21.80K | 20.43K | — | — |
| Two Sigma Investments | — | — | 39.54K | 94.01K | 45.79K | — | — | — | — |
| Aptus Capital Advisors, LLC | — | 44.29K | 44.29K | 44.29K | 44.29K | 44.29K | 44.29K | — | — |
| Virtu Financial LLC | — | 82.09K | — | 20.28K | — | — | — | 13.66K | 32.71K |
| SevenBridge Financial Group, LLC | — | 44.29K | 44.29K | 44.29K | 44.29K | 44.29K | 44.29K | — | — |
| Scientech Research LLC | — | — | — | — | — | — | 48.20K | — | — |
| XTX Topco Ltd | — | 14.92K | — | 48.49K | 12.41K | 62.75K | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 78.92K | — | — | — | — | — | — | — |
| TWO SIGMA SECURITIES, LLC | — | — | 16.25K | — | 24.89K | 13.55K | — | — | — |
| STATE STREET CORP | — | — | 24.10K | 24.10K | 24.10K | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold KAPA?
As of 2026-Q3, 6 institutional funds reported holding KAPA (KAIROS PHARMA LTD) in SEC 13F filings, with a combined reported value of $57.80K.
How many shares of KAPA do institutions own?
13F filers reported 35.21K shares of KAPA, worth $57.80K in aggregate at the end of 2026-Q3.
Is institutional ownership of KAPA rising or falling?
Share counts moved -90.4% versus the prior quarter — distribution.
Who are the top institutional holders of KAPA?
The largest 13F holders are ARMISTICE CAPITAL, LLC, UMB Bank, n.a., Citadel Advisors, Vanguard Group, Scientech Research LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of KAIROS PHARMA LTD?
The major shareholders of KAIROS PHARMA LTD (KAPA) by reported 13F value are ARMISTICE CAPITAL, LLC, UMB Bank, n.a., Citadel Advisors, Vanguard Group, Scientech Research LLC, among 30 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.